These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

647 related articles for article (PubMed ID: 26073311)

  • 1. Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection.
    Schulz R; Görge PM; Görbe A; Ferdinandy P; Lampe PD; Leybaert L
    Pharmacol Ther; 2015 Sep; 153():90-106. PubMed ID: 26073311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Connexin 43 and Mitochondria in Cardiovascular Health and Disease.
    Boengler K; Schulz R
    Adv Exp Med Biol; 2017; 982():227-246. PubMed ID: 28551790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Remodeling of cardiac gap junctions and arrhythmias].
    Yu ZB; Sheng JJ
    Sheng Li Xue Bao; 2011 Dec; 63(6):586-92. PubMed ID: 22193455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connexins in the Heart: Regulation, Function and Involvement in Cardiac Disease.
    Rodríguez-Sinovas A; Sánchez JA; Valls-Lacalle L; Consegal M; Ferreira-González I
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single intravenous low-dose injections of connexin 43 mimetic peptides protect ischemic heart in vivo against myocardial infarction.
    Hawat G; Hélie P; Baroudi G
    J Mol Cell Cardiol; 2012 Oct; 53(4):559-66. PubMed ID: 22841862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Connexin 43 and ischemic preconditioning.
    Schulz R; Heusch G
    Cardiovasc Res; 2004 May; 62(2):335-44. PubMed ID: 15094353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of connexin-based gap junction channels and hemichannels in ischemia-induced cell death in nervous tissue.
    Contreras JE; Sánchez HA; Véliz LP; Bukauskas FF; Bennett MV; Sáez JC
    Brain Res Brain Res Rev; 2004 Dec; 47(1-3):290-303. PubMed ID: 15572178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sufentanil limits the myocardial infarct size by preservation of the phosphorylated connexin 43.
    Wu Y; Gu EW; Zhu Y; Zhang L; Liu XQ; Fang WP
    Int Immunopharmacol; 2012 Jul; 13(3):341-6. PubMed ID: 22561119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connexin 43 mimetic peptide Gap26 confers protection to intact heart against myocardial ischemia injury.
    Hawat G; Benderdour M; Rousseau G; Baroudi G
    Pflugers Arch; 2010 Aug; 460(3):583-92. PubMed ID: 20514543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 and myocardial ischemia: potential pharmacological implication for cardioprotection.
    Barau C; Ghaleh B; Berdeaux A; Morin D
    Fundam Clin Pharmacol; 2015 Feb; 29(1):1-9. PubMed ID: 24990103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial Cx40 limits myocardial ischaemia/reperfusion injury in mice.
    Morel S; Braunersreuther V; Chanson M; Bouis D; Rochemont V; Foglia B; Pelli G; Sutter E; Pinsky DJ; Mach F; Kwak BR
    Cardiovasc Res; 2014 May; 102(2):329-37. PubMed ID: 24639196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preservation of mitochondrial function during ischemia as a possible mechanism for cardioprotection of diltiazem against ischemia/reperfusion injury.
    Takeo S; Tanonaka K; Iwai T; Motegi K; Hirota Y
    Biochem Pharmacol; 2004 Feb; 67(3):565-74. PubMed ID: 15037208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival.
    Kim HS; Cho JE; Hwang KC; Shim YH; Lee JH; Kwak YL
    Eur J Pharmacol; 2010 Feb; 628(1-3):132-9. PubMed ID: 19944681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moderate inhibition of myocardial matrix metalloproteinase-2 by ilomastat is cardioprotective.
    Bencsik P; Pálóczi J; Kocsis GF; Pipis J; Belecz I; Varga ZV; Csonka C; Görbe A; Csont T; Ferdinandy P
    Pharmacol Res; 2014 Feb; 80():36-42. PubMed ID: 24380772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of cardiac gap junction intercellular channels.
    Yeager M
    J Struct Biol; 1998; 121(2):231-45. PubMed ID: 9615440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perturbing plasma membrane hemichannels attenuates calcium signalling in cardiac cells and HeLa cells expressing connexins.
    Verma V; Hallett MB; Leybaert L; Martin PE; Evans WH
    Eur J Cell Biol; 2009 Feb; 88(2):79-90. PubMed ID: 18951659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible involvement of different connexin43 domains in plasma membrane permeabilization induced by ischemia-reperfusion.
    Retamal MA; Schalper KA; Shoji KF; Orellana JA; Bennett MV; Sáez JC
    J Membr Biol; 2007 Aug; 218(1-3):49-63. PubMed ID: 17705051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of connexin 43 in cardiovascular diseases.
    Michela P; Velia V; Aldo P; Ada P
    Eur J Pharmacol; 2015 Dec; 768():71-6. PubMed ID: 26499977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of connexin hemichannel activity by membrane potential and the extracellular calcium in health and disease.
    Fasciani I; Temperán A; Pérez-Atencio LF; Escudero A; Martínez-Montero P; Molano J; Gómez-Hernández JM; Paino CL; González-Nieto D; Barrio LC
    Neuropharmacology; 2013 Dec; 75():479-90. PubMed ID: 23587648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Connexin targeting peptides as inhibitors of voltage- and intracellular Ca2+-triggered Cx43 hemichannel opening.
    Wang N; De Bock M; Decrock E; Bol M; Gadicherla A; Bultynck G; Leybaert L
    Neuropharmacology; 2013 Dec; 75():506-16. PubMed ID: 24007825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.